EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of key metabolic enzymes involved in the activation of obeldesivir and remdesivir to the active triphosphate metabolite

Yili Xu iD, Albert Liclican, Xiaofeng Zhao, Chen Chen, Joseph T Ortega, Hsiu-Chun Chuang, Cameron Soulette, Subhra Chaudhuri, Jingyu Zhang, Ting Wang, Darius Babusis, Bruno Marchand und 14 weitere

Antimicrobial Agents and Chemotherapy · 05.08.2026 · 70 (8)

DOI: 10.1128/aac.00055-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 05.08.2026. Verfasst von Yili Xu und 25 weiteren Autor:innen. Beteiligte Einrichtung: Gilead Sciences, Inc., Foster City, California, USA. Hauptthemen laut MEDLINE: Adenosine Monophosphate, Antiviral Agents, Alanine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gilead Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obeldesivir (GS-5245, ODV), an orally administered 5′-isobutyryl ester prodrug of GS-441524, has demonstrated anti-SARS-CoV-2 activity in preclinical and clinical settings. ODV is hydrolyzed in plasma to provide high systemic exposures of GS-441524, enabling the efficient intracellular formation of the bioactive 5′-triphosphate GS-443902, an ATP analog inhibiting the SARS-CoV-2 RNA-dependent RNA polymerases. Remdesivir (RDV), the first US FDA-approved antiviral treatment for COVID-19, is also activated to GS-443902. In this paper, we systematically profiled the human enzymes potentially involved in ODV and RDV activation using multiple approaches: (i) biochemical studies on the catalytic efficiency ( k cat / K m ); (ii) analysis of activation in single-gene knockout cells; and (iii) the antiviral activity assessment in single-gene knockout cells. Our results demonstrated that ODV hydrolysis to GS-441524 is catalyzed by carboxylesterase 1 and 2 with high efficiency. For the enzymes involved in the consecutive formation of 5′-mono-, di-, and tri-phosphates (MP, DP, and TP), adenosine kinase (ADK) likely plays a minor role in forming GS-441524-MP, suggesting the involvement of other phosphotransferases. This was further supported by cell-based single-gene ADK-knockout studies. In contrast, both biochemical and cell-based assay data strongly support adenylate kinase 2 as the key enzyme for the phosphorylation of GS-441524-MP, while nucleoside diphosphate kinase NM23-H2, phosphoglycerate kinase, and pyruvate kinase likely all contribute to the formation of GS-441524-TP. This work leads to a deeper understanding of ODV and RDV metabolism, and suggests further studies are needed to identify the enzyme responsible for the activation of GS-441524 to its 5′-monophosphate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenosine MonophosphateAntiviral AgentsAlanineHumansSARS-CoV-2ProdrugsCOVID-19 Drug TreatmentAdenosine TriphosphateAdenosine

Stichwörter der Autor:innen

GS-441524ODVactivation pathwayobeldesivirphosphotransferases

Substanzen

Adenosine MonophosphateremdesivirAntiviral AgentsAlanineGS-441524GS-441524 triphosphateProdrugsAdenosine TriphosphateAdenosine

Autor:innen und Institutionen

  • Gilead Sciences, Inc., Foster City, California, USA.
  • Department of Animal Biosciences, Swedish University of Agricultural Sciences, Uppsala, Sweden.

ORCID-Profile: Yili Xu, Ricardo Ramirez, Li Li, Latesh Lad

Förderung

  • Gilead Sciences

Zitieren

APA

Xu, Y., Liclican, A., Zhao, X., Chen, C., Ortega, J. T., Chuang, H. C., Soulette, C., Chaudhuri, S., Zhang, J., Wang, T., Babusis, D., Marchand, B., Sun, K., Ramirez, R., Ma, B., Nayak, A., Wang, L., Menon, S., Belzile, J. P., …, & Lad, L. (2026). Identification of key metabolic enzymes involved in the activation of obeldesivir and remdesivir to the active triphosphate metabolite. Antimicrobial Agents and Chemotherapy, 70(8). https://doi.org/10.1128/aac.00055-26

Vancouver

Xu Y, Liclican A, Zhao X, Chen C, Ortega JT, Chuang HC, et al. Identification of key metabolic enzymes involved in the activation of obeldesivir and remdesivir to the active triphosphate metabolite. Antimicrobial Agents and Chemotherapy. 2026;70(8). doi:10.1128/aac.00055-26

BibTeX
@article{Xu2026,
  author = {Xu, Yili and Liclican, Albert and Zhao, Xiaofeng and Chen, Chen and Ortega, Joseph T and Chuang, Hsiu-Chun and Soulette, Cameron and Chaudhuri, Subhra and Zhang, Jingyu and Wang, Ting and Babusis, Darius and Marchand, Bruno and Sun, Kai-Hui and Ramirez, Ricardo and Ma, Bin and Nayak, Arabinda and Wang, Liya and Menon, Saurabh and Belzile, Jean-Philippe and Lai, Yurong and Li, Li and Mackman, Richard L and Bilello, John P and Cihlar, Tomas and Feng, Joy Y and Lad, Latesh},
  title = {Identification of key metabolic enzymes involved in the activation of obeldesivir and remdesivir to the active triphosphate metabolite},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  volume = {70},
  number = {8},
  doi = {10.1128/aac.00055-26}
}
Kostenlos starten →